| __timestamp | Alnylam Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 2395000 |
| Thursday, January 1, 2015 | 276495000 | 9057000 |
| Friday, January 1, 2016 | 382392000 | 40818000 |
| Sunday, January 1, 2017 | 390635000 | 79309000 |
| Monday, January 1, 2018 | 505420000 | 134428000 |
| Tuesday, January 1, 2019 | 655114000 | 175431000 |
| Wednesday, January 1, 2020 | 654819000 | 130944000 |
| Friday, January 1, 2021 | 792156000 | 121875000 |
| Saturday, January 1, 2022 | 883015000 | 115856000 |
| Sunday, January 1, 2023 | 1004415000 | 130009000 |
| Monday, January 1, 2024 | 1126232000 |
Data in motion
In the competitive world of biotechnology, innovation is the key to success. Alnylam Pharmaceuticals and Wave Life Sciences are two companies that have consistently invested in research and development (R&D) to drive their growth. Over the past decade, Alnylam Pharmaceuticals has demonstrated a robust commitment to innovation, with R&D expenses increasing by over 400% from 2014 to 2023. In contrast, Wave Life Sciences, while also increasing its R&D spending, has seen a more modest growth of around 54% during the same period.
Alnylam's R&D investment peaked in 2023, reaching nearly five times that of Wave Life Sciences. This significant difference highlights Alnylam's aggressive strategy to lead in the biotech sector. As the industry continues to evolve, the commitment to R&D will likely play a crucial role in determining which company will emerge as a leader in innovation.
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Wave Life Sciences Ltd.
GSK plc vs Alnylam Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. vs Madrigal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Wave Life Sciences Ltd.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.